The event organized by the partnership between Tecniche Nuove and Pharmintech on pharmaceutical production will take place on Wednesday 10 April in Bologna.
It will be the place where to discuss the new challenges and opportunities in this area with a major current focus on the SPC manufacturing waiver.
SPC manufacturing waiver
It has been discussed for long time. This is the SPC manufacturing waiver, for quicker access to medicines for patients. The event will be an opportunity to take stock of the steps that Europe has taken in recent months and to discuss, in real time about the direction to take and of future steps.
The last update available concerns the current compromise which the Trilogue would seem to have arrived at the end of February. The decisions, however, are still in progress, and the compromise amendments on which the Trilogue was agreed should be able to be adopted by the end of the current term of the European Parliament.
Event details on “Pharmaceutical production: new challenges and opportunities”
To register for the event you must follow these instructions.
The detailed program is as follows:
15.00-15.30 – The market of active pharmaceutical ingredients: lights and shadows – Paolo Russolo (Aschimfarma)
15.30-16.00 – The production challenges. What innovations companies must implement to remain competitive – Alessandro Fava and Gianni Gottardo (FIS Fabbrica Italiana Sintetici)
16.00-16.30 – Traceability of pharmaceutical raw materials – Piero Iamartino (AFI)
4.30pm – 5.00pm – EU single market strategy: the SPC revolution in the EU in the world productive and competitive scenario – Sergio Napolitano (Medicines for Europe) or EU Commission representative (awaiting confirmation)
17-00-17.30 – Round table “SPC manufacturing waiver: opportunities and challenges“, with the participation of Afi, Aschimfarma, Assogenerici, EU Commission (pending confirmation), Ispe, Medicines for Europe